Evommune, Inc.: Clinical Trials

7 trials sponsored by Evommune, Inc., newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 completed, 2 recruiting. 6 Phase 2, 1 Early Phase 1.

By phase and status

PhaseTrialsStatus
Phase 26Completed 5, Recruiting 1
Early Phase 11Recruiting 1

Follow Evommune, Inc.: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study of EVO756 in Adults With Migraine
EVO756, Dose 1, EVO756, Dose 2, Placebo - Migraine
Phase 2RecruitingEvommune, Inc.3302026-07-292026-11-04
Phase 2b Study of EVO756 in Adults With Atopic Dermatitis
EVO756, Placebo control - Atopic Dermatitis
Phase 2CompletedEvommune, Inc.1212025-08-262026-10-05
Phase 2b Study of EVO756 in Adults With Moderate to Severe Chronic Spontaneous Urticaria (CSU)
EVO756, Placebo control - Chronic Spontaneous Urticaria
Phase 2CompletedEvommune, Inc.1822025-03-202026-07-01
Efficacy Study of EVO301 in Moderate to Severe Atopic Dermatitis
EVO301, Placebo - Atopic Dermatitis (AD), Eczema
Phase 2CompletedEvommune, Inc.712025-02-132025-12-04
Participants with Mild to Moderate Hidradenitis Suppurativa Will Receive EVO101 a Topical Cream 0.1%
EVO101 - Hidradenitis Suppurativa (HS)
Early Phase 1RecruitingVirginia Clinical Research, Inc.152024-12-032024-12-11
A Study Evaluating the Safety, Tolerability, and Efficacy of EVO756 in Adults With Chronic Inducible Urticaria
Oral EVO756 300 mg QD, Oral EVO756 50 mg BID - Chronic Inducible Urticaria
Phase 2CompletedEvommune, Inc.302024-08-142026-05-19
Safety and Efficacy Study of EVO101 Topical Cream in Atopic Dermatitis
EVO101 - Atopic Dermatitis Eczema
Phase 2CompletedEvommune, Inc.1192022-09-272025-03-05

Conditions studied

Dermatitis, Atopic (2)  ·  Eczema (2)  ·  Chronic Inducible Urticaria (1)  ·  Chronic Urticaria (1)  ·  Hidradenitis Suppurativa (1)  ·  Migraine Disorders (1)  ·  Migraine with Aura (1)  ·  Migraine without Aura (1)  ·  Pruritus (1)  ·  Urticaria (1)

Interventions

BID protein, human (1)

Countries

United States (6)  ·  New Zealand (3)  ·  Australia (2)  ·  Canada (2)  ·  Japan (1)

Top investigators

Eugene Bauer, MD (1)